The Prevalence of Chronic Kidney Disease in a Primary Care Setting: A Swiss Cross-Sectional Study

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Tomonaga, Yuki ^a   Risch, Lorenz ^b,c   Szucs, Thomas D ^d   Ambuehl, Patrice M ^e  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Labormedizinische Zentren Dr Risch   (Switzerland)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d UNIVERSITY OF BASEL   (Switzerland)

^e Stadtspital Waid   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALBUMINURIA; ARTICLE; BLOOD ANALYSIS; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENERAL PRACTITIONER; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE IMPROVING GLOBAL OUTCOMES; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIMARY MEDICAL CARE; PROTEINURIA; QUESTIONNAIRE; RANDOM SAMPLE; SEX DIFFERENCE; SWITZERLAND; URINALYSIS; URINARY EXCRETION;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PREVALENCE; PRIMARY HEALTH CARE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SWITZERLAND;

EID: 84879771793     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067848     Document Type: Article

References (53)

1. Eknoyan G, Lameire N, Barsoum R, Eckardt KU, Levin A, et al. (2004) The burden of kidney disease: improving global outcomes. Kidney international 66: 1310-1314.
2. Thorp ML, Eastman L, Smith DH, Johnson ES, (2006) Managing the burden of chronic kidney disease. Dis Manag 9: 115-121.
3. Al-Aly Z, Zeringue A, Fu J, Rauchman MI, McDonald JR,et al. Rate of kidney function decline associates with mortality. J Am Soc Nephrol 21: 1961-1969.
4. Chen YC, Su YC, Lee CC, Huang YS, Hwang SJ Chronic kidney disease itself is a causal risk factor for stroke beyond traditional cardiovascular risk factors: a nationwide cohort study in Taiwan. PloS one 7: e36332.
5. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, et al. (1999) Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney international 56: 2214-2219.
6. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY, (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. The New England journal of medicine 351: 1296-1305.
7. Hallan SI, Matsushita K, Sang Y, Mahmoodi BK, Black C,et al. Age and association of kidney measures with mortality and end-stage renal disease. Jama 308: 2349-2360.
8. McCullough PA, Li S, Jurkovitz CT, Stevens L, Collins AJ, et al. (2008) Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality. American heart journal 156: 277-283.
9. Roderick PJ, Atkins RJ, Smeeth L, Mylne A, Nitsch DD, et al. (2009) CKD and mortality risk in older people: a community-based population study in the United Kingdom. Am J Kidney Dis 53: 950-960.
10. Ryan TP, Fisher SG, Elder JL, Winters PC, Beckett W, et al. (2009) Increased cardiovascular risk associated with reduced kidney function. American journal of nephrology 29: 620-625.
11. Wang HE, Gamboa C, Warnock DG, Muntner P Chronic kidney disease and risk of death from infection. American journal of nephrology 34: 330-336.
12. Weiner DE, Krassilnikova M, Tighiouart H, Salem DN, Levey AS, et al. (2009) CKD classification based on estimated GFR over three years and subsequent cardiac and mortality outcomes: a cohort study. BMC nephrology 10: 26.
13. Ting SM, Nair H, Ching I, Taheri S, Dasgupta I (2009) Overweight, obesity and chronic kidney disease. Nephron 112: c121-127; discussion c127.
14. Stevens LA, Viswanathan G, Weiner DE Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance. Advances in chronic kidney disease 17: 293-301.
15. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, et al. (2005) Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney international 67: 2089-2100.
16. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC,et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney international 80: 17-28.
17. Mucsi I, Kovacs AZ, Molnar MZ, Novak M, (2008) Co-morbidity and quality of life in chronic kidney disease patients. Journal of nephrology 21Suppl 13: S84-91.
18. Powe NR, Plantinga L, Saran R, (2009) Public health surveillance of CKD: principles, steps, and challenges. Am J Kidney Dis 53: S37-45.
19. Locatelli F, Del Vecchio L, Pozzoni P, Manzoni C, (2006) Nephrology: main advances in the last 40 years. Journal of nephrology 19: 6-11.
20. Bommer J, (2002) Prevalence and socio-economic aspects of chronic kidney disease. Nephrol Dial Transplant 17Suppl 11: 8-12.
21. Swiss Federal Office of Public Health (FOPH), Kosten der Transplantationsmedizin. http://www.bag.admin.ch/transplantation/00692/02582/03136/index.html?lang=de. Accessed 03 May 2013.
22. Damman K, van Veldhuisen DJ, Navis G, Voors AA, Hillege HL, (2008) Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure. European journal of heart failure 10: 997-1000.
23. White SL, Cass A, Atkins RC, Chadban SJ, (2005) Chronic kidney disease in the general population. Advances in chronic kidney disease 12: 5-13.
24. Kurella Tamura M, Anand S, Li S, Chen SC, Whaley-Connell AT,et al. Comparison of CKD awareness in a screening population using the Modification of Diet in Renal Disease (MDRD) study and CKD Epidemiology Collaboration (CKD-EPI) equations. Am J Kidney Dis 57: S17-23.
25. Murphree DD, Thelen SM Chronic kidney disease in primary care. J Am Board Fam Med 23: 542-550.
26. Levin A, Hemmelgarn B, Culleton B, Tobe S, McFarlane P, et al. (2008) Guidelines for the management of chronic kidney disease. Cmaj 179: 1154-1162.
27. Allen AS, Forman JP, Orav EJ, Bates DW, Denker BM,et al. Primary care management of chronic kidney disease. Journal of general internal medicine 26: 386-392.
28. Whaley-Connell AT, Sowers JR, Stevens LA, McFarlane SI, Shlipak MG, et al. (2008) CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 51: S13-20.
29. Zhang QL, Rothenbacher D, (2008) Prevalence of chronic kidney disease in population-based studies: systematic review. BMC public health 8: 117.
30. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS, (2003) Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41: 1-12.
31. Levey AS, Stevens LA Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis 55: 622-627.
32. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, et al (2009) A new equation to estimate glomerular filtration rate. Annals of internal medicine 150: 604-612.
33. Levey AS, Tangri N, Stevens LA Classification of chronic kidney disease: a step forward. Annals of internal medicine 154: 65-67.
34. Selvin E, Kottgen A, Coresh J, (2009) Kidney function estimated from serum creatinine and cystatin C and peripheral arterial disease in NHANES 1999-2002. European heart journal 30: 1918-1925.
35. Forni V, Glatz N, Conen D, Stettler H, Paccaud F, et al. (2011) Prevalence of Chronic Kidney Disease in the Population-Based Swiss Survey on Salt. Swiss med wkly (Suppl 191): 21S.
36. Szewczyk M, Wielkoszynski T, Zakliczynski M, Zembala M, (2009) Plasma neutrophil gelatinase-associated lipocalin (NGAL) correlations with cystatin C, serum creatinine, and glomerular filtration rate in patients after heart and lung transplantation. Transplantation proceedings 41: 3242-3243.
37. Whaley-Connell A, Sowers JR, McCullough PA, Roberts T, McFarlane SI, et al. (2009) Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES). Am J Kidney Dis 53: S11-21.
38. McCullough PA, Li S, Jurkovitz CT, Stevens LA, Wang C, et al. (2008) CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 51: S38-45.
39. Figueiredo EL, Leao FV, Oliveira LV, Moreira MC, Figueiredo AF, (2008) Microalbuminuria in nondiabetic and nonhypertensive systolic heart failure patients. Congestive heart failure (Greenwich, Conn 14: 234-238.
40. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of internal medicine 130: 461-470.
41. Risch L, Saely CH, Neyer U, Hoefle G, Gouya G, et al. (2007) Prevalence of decreased glomerular filtration rate in patients seeking non-nephrological medical care-an evaluation using IDMS-traceable creatinine based MDRD as well as Mayo Clinic quadratic equation estimates. Clinica chimica acta; international journal of clinical chemistry 378: 71-77.
42. Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, et al. (2004) Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Annals of internal medicine 141: 929-937.
43. Rigalleau V, Lasseur C, Raffaitin C, Perlemoine C, Barthe N, et al. (2007) The Mayo Clinic quadratic equation improves the prediction of glomerular filtration rate in diabetic subjects. Nephrol Dial Transplant 22: 813-818.
44. Stevens LA, Li S, Kurella Tamura M, Chen SC, Vassalotti JA,et al. Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 57: S9-16.
45. Matsushita K, Tonelli M, Lloyd A, Levey AS, Coresh J,et al. Clinical Risk Implications of the CKD Epidemiology Collaboration (CKD-EPI) Equation Compared With the Modification of Diet in Renal Disease (MDRD) Study Equation for Estimated GFR. Am J Kidney Dis.
46. Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH,et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. Jama 307: 1941-1951.
47. Giavarina D, Cruz DN, Soffiati G, Ronco C Comparison of estimated glomerular filtration rate (eGFR) using the MDRD and CKD-EPI equations for CKD screening in a large population. Clinical nephrology 74: 358-363.
48. Bottomley MJ, Kalachik A, Mevada C, Brook MO, James T,et al. Single estimated glomerular filtration rate and albuminuria measurement substantially overestimates prevalence of chronic kidney disease. Nephron 117: c348-352.
49. Wetzels JF, Kiemeney LA, Swinkels DW, Willems HL, den Heijer M, (2007) Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int 72: 632-637.
50. Hemmelgarn BR, Zhang J, Manns BJ, Tonelli M, Larsen E, et al. (2006) Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int 69: 2155-2161.
51. Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A, (2009) Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 54: 1012-1024.
52. O'Hare AM, Bertenthal D, Covinsky KE, Landefeld CS, Sen S, et al. (2006) Mortality risk stratification in chronic kidney disease: one size for all ages? J Am Soc Nephrol 17: 846-853.
53. Smith DH, Gullion CM, Nichols G, Keith DS, Brown JB, (2004) Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population. J Am Soc Nephrol 15: 1300-1306.